Quest Diagnostics (DGX) Equity Income (2009 - 2026)

Quest Diagnostics has disclosed Equity Income across 18 years of filings, most recently posting $4.0 million for Q1 2026.

• Equity Income for Q1 2026 came in at $4.0 million, down 77.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.0 million (down 3.45% YoY), and the FY2025 annual result was $42.0 million, up 121.05% from the prior year.
• Equity Income came in at $4.0 million for Q1 2026 at Quest Diagnostics, down from $7.0 million in the prior quarter.
• In the past five years, Equity Income ranged from a high of $31.0 million in Q1 2022 to a low of $3.0 million in Q4 2022.
• The 5-year median for Equity Income is $6.5 million (2022), against an average of $8.4 million.
• Across the five-year window, Equity Income sank 88.0% in 2022 and surged 166.67% in 2023, its largest moves.
• Quest Diagnostics' Equity Income stood at $3.0 million in 2022, then soared by 166.67% to $8.0 million in 2023, then plunged by 37.5% to $5.0 million in 2024, then surged by 40.0% to $7.0 million in 2025, then plunged by 42.86% to $4.0 million in 2026.
• The last three Equity Income figures came in at $4.0 million (Q1 2026), $7.0 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.